To test the effects on abdominal fat reduction of adding aerobic exercise training to a diet program and obesity phenotype in response to weight loss. DESIGN: A prospective clinical trial with a 14-week weight-loss intervention design. SETTING AND PARTICIPANTS: In total, 209 overweight and obese women were assigned to four subgroups depending on type of treatment and the subject's obesity phenotype: diet alone (DA) with intra-abdominal fat (IF) obesity (Zmean IF area), diet plus exercise (DE) with IF obesity, DA with abdominal subcutaneous fat (ASF) obesity (omean IF area) and DE with ASF obesity. Abdominal fat areas were evaluated by CT scans, with values adjusted for selected variables. RESULTS: Values were adjusted for age, menopausal status and change in body weight and total fat mass. The IF reductions were significantly (Po0.0001) greater in subjects with IF obesity phenotype (À45.1 cm 2 ) compared to the ASF obesity phenotype (À22.2 cm 2 ). The ASF reductions were significantly (Po0.001) greater for subjects with ASF obesity (À74.5 cm 2 ) compared to IF obesity (À55.5 cm 2 ). For IF obesity, the IF reduction was significantly (Po0.01) greater in the DE group (À49.3 cm 2 ) than in the DA group (À37.8 cm 2 ). CONCLUSION: These results suggest that for individuals with IF obesity, the efficacy on reducing IF of adding aerobic exercise training to a diet-alone weight-reduction program is more prominent (À49.3 cm 2 /À37.8 cm 2 ¼ 1.3 times) compared with DA. Moreover, abdominal fat reduction was found to be modified by obesity phenotype in response to weight loss.
Introduction
Obesity is closely associated with some major health risk factors, 1, 2 and the prevalence of obesity continues to increase in developed countries. 3 It is well known that individuals with central (android-type) obesity are at greater risk for coronary heart disease (CHD) and several metabolic disorders. 4 Although waist circumference and waist-to-hip ratio continue to be widely used anthropometric indices for determining central fat obesity, 5, 6 intra-abdominal fat (IF) measured by computerized tomography (CT) scans is also an index for evaluating abdominal adiposity. The IF accumulation is strongly associated with metabolic disorders independent of whole-body adiposity, including high blood pressure and triglycerides as well as an increased incidence of diabetes mellitus. [7] [8] [9] Since it is known that weight-loss treatment benefits the health of obese individuals, [10] [11] [12] obese patients with risk factors for CHD should be treated by an appropriate weightloss program. Unfortunately, losing weight through diet alone (DA) includes a decline in fat-free mass during the intervention period 12 and induces an attenuation of fat oxidation after the intervention period, 13 which may contribute to weight regain. To prevent regaining weight after weight loss, therefore, it has been recommended that obesity be treated with exercise training in addition to reduced energy intake. 14 It is unclear whether aerobic exercise training improves total and abdominal obesity. 15, 16 Several studies reported that aerobic exercise training, for example, walking, stair climbing, stationary cycling and aerobics, which were prescribed for treating obesity, do not always play an important role in weight loss. [17] [18] [19] Some studies have demonstrated that physical activity was associated with IF reduction, [20] [21] [22] [23] but others found no association. 24, 25 In addition, sample sizes of these studies were too small to provide conclusive evidence that exercise training actually reduces IF. A report from the National Institutes of Health states that there is insufficient evidence to determine whether an increase in physical activity is associated with a corresponding reduction in abdominal obesity in a doseresponse manner. 26 Nevertheless, Shimomura et al 27 
Subjects and methods

Subjects
In total, 303 women were recruited through advertisements in local newspapers. Through medical history and physical examination, we excluded individuals who were nonobese or nonoverweight (body mass index less than 25 kg/m 2 ), 28 smoked, had concomitant renal, hepatic or cardiac disease, or were being treated with drugs such as beta-blockers, which could affect the variables of the study. In total, 225 women, aged 21-66 y, were chosen as subjects. To increase subjects' adherence to the weight-reduction programs, the subjects' personal lifestyle (occupations, daily schedules, etc) was taken into account and they were placed in either a DA group (n ¼ 73) or a diet plus exercise (DE) group (n ¼ 152 , n ¼ 104). Assays and measurements were carried out before and after the 14-week intervention period. The aim and design of the study were explained to each subject before they gave their written informed consent. This study was approved by the Higashi Toride Hospital Review Board.
Anthropometric variables
Body weight was measured to the nearest 0.1 kg using a digital scale, height was measured to the nearest 0.1 cm using a wall-mounted stadiometer, and BMI was calculated as weight (kg) divided by height squared (m 2 ).
Body composition by bioelectrical impedance analysis Body composition, recorded as percentage fat mass, absolute total fat mass (kg) and fat-free mass (kg), was assessed by a bioelectrical impedance analysis at 50 kHz (SS-103, Sekisui, Tokyo, Japan). 29 Measurements were conducted with subjects in the supine position after at least a 20-min rest.
Abdominal adipose tissue area by CT
The IF and ASF areas (cm 2 ) were measured at the level of the umbilicus (L4-L5) using CT scans (SCT-6800TX, Shimadzu, Tokyo, Japan) performed on subjects in the supine position. The IF and ASF areas were calculated using a computer software program (FatScan, N2system, Osaka, Japan). 30 The intraclass correlation for repeated IF and ASF areas determinations in our laboratory are 0.99.
Assessment of CHD risk factors
Systolic and diastolic blood pressures were taken from the left arm using a sphygmomanometer after the subjects rested at least 20 min in a sitting position. Cuff sizes were selected based on upper arm girth and length. A blood sample of approximately 10 ml was drawn from each subject after an overnight fast. Serum total cholesterol and triglycerides were determined enzymatically, and fasting plasma glucose was assayed by a glucose oxidase method. Serum high-density lipoprotein-cholesterol was measured by the heparin-manganese precipitation method. Five criteria for CHD risk factors were defined: (1) systolic blood pressure Z140 mmHg; (2) diastolic blood pressure Z90 mmHg; (3) total cholesterol Z5.70 mmol/l (220 mg/dl); (4) triglycerides Z1.70 mmol/l (150 mg/dl); (5) fasting plasma glucose Z7.00 mmol/l (126 mg/dl). Frequencies and percentages of subjects with high systolic blood pressure, diastolic blood pressure, total cholesterol, triglycerides and fasting plasma glucose were 75 (36%), 60 (29%), 95 (45%), 36 (17%) and 11 (5%), respectively.
Maximal oxygen uptake. Maximal oxygen uptake (VO 2max , ml/kg/min) was determined during a graded exercise test using a cycle ergometer (818E, Monark, Stockholm, Sweden). Following a 2-min warm-up, the subject started with a
Aerobic exercise and abdominal fat T Okura et al workload of 15 W, which was increased by 15 W each minute until volitional exhaustion occurred. Pulmonary ventilation and gas exchange were measured breath-by-breath with an on-line data acquisition system (Oxycon alpha System, Mijnhardt, Breda, Netherlands).
Diet and exercise regimens
Dietary protocol. All subjects were instructed to take a wellbalanced supplemental food product (MicroDiet, SunnyHealth, Nagano, Japan) every day. It was developed for very low-energy diets (170 kcal per pack) and is comprised of protein, carbohydrates, fat, various amino acids, vitamins and minerals. Two other meals per day were allowed consisting an average of 240 kcal of protein, 480 kcal of carbohydrate and 240 kcal of fat. Subjects also kept daily food diaries during the 14-week intervention period and learned about proper daily nutrition through weekly lectures and counseling by skilled dieticians. They were asked to record the brand name and amounts (in grams) of every food and beverage ingested with each meal. To calculate energy intake (in kilocalories) and the amounts of each nutrient (fat, protein, and carbohydrate in grams), data from 12 days (3 days/week: 2 weekdays and either Saturday or Sunday before the intervention period; 9 days: 3 days/months for 3 months during the intervention period) were randomly selected from the food diaries. Skilled dieticians analyzed the data (Table 1) .
Exercise protocol. In addition to restricting energy intake, the subjects from the DE group performed a bench stepping exercise 3 days/week for 45 min per session supervised in the hospital by two or three physical trainers. The bench stepping exercise is a combination exercise of low impact aerobic dance and stepping with a step bench (10-20 cm high). 31 The exercise started with basic steps for the first four weeks and then progressed to combination of basic steps and lunge steps for the next six weeks, and finally progressed to more advanced lunge steps for the last four weeks. Subjects were instructed to perform the aerobic dance at a level that raised their heart rate to 70-85% of the corresponding heart rate at their VO 2max . The target Borg's scale (ratings of perceived exertion) 32 ranged from 13 (fairly hard) to 17 (very hard). The oxygen costs of the bench stepping exercise were measured three times (at first, middle and last month) during the study by the aforementioned metabolic measurement system. Moreover, they were instructed to walk every day around their houses for more than 30 min per session. The target exercise intensity was set at a level that raised their heart rate to 40-50% of the corresponding heart rate at their VO 2max , or 9 (very light) to 11 (light) of the Borg's scale. They were instructed how to measure their heart rates by palpation while walking every week. At that time, portable heart rate monitors monitored their heart rates. Hence, they could check the validity of their heart rates by palpation. They were asked to every day record the duration (min) and intensity (heart rate and the Borg's scale) of the walking each session. According to subjects' diary (body weight, heart rate and walking time), energy expenditure while walking was calculated every day each subject using below equation. 33 Energy expenditure (kcal) ¼ 5.04 (kcal) Â VO 2max (ml/kg/ min) Â percentage heart rate reserve during walking Â body weight (kg) Â duration (min)/1000 ml.
Statistical analysis
Values are expressed as mean7standard deviations in tables and as mean7standard errors in figures. Unpaired t-tests were used to test difference in changes in variables between the two treatment groups. The relationship between two measurement variables was assessed by Pearson's product moment correlation. Correlation coefficients were compared using a test based on z-transformed correlation coefficients. Multiple regression analyses with the forward stepwise method were performed to estimate the independent contribution of age, treatment, pre-or postmenopausal status, total fat mass change and baseline IF or ASF area to the variations in changes in IF and ASF area. General linear model analyses (repeated measure ANOVA with post hoc tests) were used to test for differences in dependent variables among four subgroups (DA and DE groups with IF obesity, and DA and DE groups with ASF obesity) with selected variables as covariates.
Analyses were performed on log-transformed values for the variables that were not normally distributed. Probability values below 0.05 were regarded as significant. The data were analyzed with the Statistical Analysis System (SAS), version 8.2 (SAS Institute Inc, Cary, NC, USA).
Results
Attendance at the bench stepping exercise (40 sessions) averaged 92% (range 83-100%) for the subjects from the DE group. There were 55 subjects whose diaries were available for calculating energy expenditure. The average VO 2 during the bench stepping exercise was 19.574.7 ml/kg/min (first month 17.372.6 ml/kg/min, second month 19.873.1 ml/ kg/min and last month 21.373.6 ml/kg/min), which corresponded to 81.5714.7% of VO 2max (first month 72.479.8%, No difference was observed in intakes of total energy, proteins, fat and carbohydrates between the DA and DE groups either at baseline or during weight loss (Table 1) . Table 2 shows subjects' measurement variables at baseline, and changes in the variables by treatment group and obesity phenotype. We compared these changes between treatment groups and obesity phenotype by considering the subjects as four subgroups: IF obesity in DA group, IF obesity in DE group, ASF obesity in DA group and ASF obesity in DE group. For the IF obesity phenotype, decreases in body weight, body mass index, percentage fat mass and fat mass were significantly greater in the DE group than in the DA group (Po0.001). Abdominal fat areas (Po0.01), and diastolic blood pressure and fasting plasma glucose (Po0.05) were also reduced to a much greater extent in the DE group than in the DA group. Furthermore, subjects in the DE group had a larger increase in VO 2max than subjects in the DA group. For the ASF obesity phenotype, no significant difference was found between the two treatment groups with the exception of VO 2max . Figure 1 shows the comparison of fat mass change among the four subgroups. Values were adjusted for age, menopausal status, baseline fat mass and change in body weight. We also compared changes in IF areas among the four subgroups after adjusting for age, menopausal status, and changes in body weight and total fat mass (Figure 2 ). The IF 
IF obesity ASF obesity Change in total fat mass (kg)
Group with diet alone Group with diet plus exercise ). However, there was no difference in the reduction of the ASF area between the DA and DE groups.
We quantified the independent contributions to the variances in the IF and ASF areas (Table 3) . For the IF obesity phenotype, the reduction in IF area had a significant relationship to baseline IF area (Po0.0001), treatment (P ¼ 0.0001) and pre-or postmenopausal status (P ¼ 0.0024), and the reduction in ASF area was significantly related only to total fat mass rduction (Po0.0001). For the ASF obesity phenotype, reduction in IF area was related to baseline IF area (Po0.0001) and total fat mass reduction (P ¼ 0.0018), and the reduction in ASF area had a relationship to total fat mass reduction (Po0.0001) and baseline ASF area (P ¼ 0.023). y Po0.05: significant difference from DA group with ASF obesity. Aerobic exercise and abdominal fat T Okura et al Figure 4 shows the relationships between total fat mass change and changes in IF area and ASF area. The correlation coefficient between changes in ASF area and total fat mass (r ¼ 0.52, Po0.0001) was significantly larger than that between changes in IF area and total fat mass (r ¼ 0.24, Po0.01).
Discussion
Subjects with IF obesity had greater reductions in IF areas compared to subjects with ASF obesity (Figure 2 ), suggesting that obesity phenotype modifies IF reduction in response to weight loss. Obesity phenotype also modified ASF reduction in response to weight loss. Moreover, our data revealed that for individuals with IF obesity, the efficacy of adding aerobic exercise on reducing IF is more prominent (À49.3 cm 2 / À37.8 cm 2 ¼ 1.3 times) compared with DA.
Irwin et al 34 reported that an increase in duration (min/ week) of physical activity had a significant association with the reduction of total fat, and a review by Ross and Janssen 16 suggested that an increase (Z1500 kcal/week) in physical activity for a short period (r16 week) was associated with a reduction in total fat mass in a dose-response manner. Our study period was 14 weeks and the estimated energy expenditure during exercise was about 2000 kcal/week, which met the above criteria for reducing body fat. For the IF obesity phenotype (Table 2) , reduction in total fat mass was greater in the DE group than in the DA group, which was attributable to the fact that weight loss was greater in the DE group than in the DA group. These results may simply reflect the difference between the negative energy balance of the two treatment groups for the IF obesity phenotype (DA À6069 kcal/week and DE À8084 kcal/week), and the significant difference in total fat mass change between the DA and DE groups did disappear when adjusted for the selected variables including body weight change (Figure 1 ). This means that total fat reduction per unit of negative energy balance by diet was equivalent to that by exercise training. That is, efficacy of exercise training on total fat reduction was equivalent to that of diet. Therefore, our data suggest that, with a strictly supervised weight loss program, exercise training could have a positive effect on reducing total fat and body weight. ). Since reductions in total abdominal fat areas were similar among the subgroups with the exception of IF obesity in the DE group, the IF reductions and ASF reductions may be compensating each other. It is still unclear whether a threshold exists below which the IF and ASF mobilization in the weight loss response is markedly reduced.
There is insufficient evidence to determine whether an increase in physical activity is associated with a corresponding reduction in abdominal obesity in a dose-response manner. 26 According to a review by Ross and Janssen, 16 only six studies, including three randomized, controlled studies 20, 21, 24 and three nonrandomized studies, 22, 23, 25 Aerobic exercise and abdominal fat T Okura et al measured by computed tomography scan or magnetic resonance imaging. From these studies, Ross and Janssen concluded that, although physical activity was associated with a reduction in IF area, it is not possible to establish a dose-response relationship. 16 However, sample sizes of these previous studies might be too small to provide conclusive evidence that exercise training actually reduces IF. In the present study, sample size required to observe a significant difference in IF area and ASF area between the groups with the DA and DE of the IF obesity was calculated when a significance level of 0.05 (a) and 80% of the power (b) of the test were used. The sample sizes were 68 and 57 for IF area and ASF area, respectively, which are less than our sample size (sum total number of IF obesity ¼ 105). This suggests that these differences between the groups with the DA and DE were statistically relevant in the IF obesity. Therefore, it is hardly for our results to be concomitant with a type II error. Therefore, our data may provide evidence that efficacy of exercise training for reducing IF may exceed by 1.3 times that of DA only for subjects with the IF obesity phenotype; the specific effect of exercise was modified by obesity phenotype.
The reason as to why this effect was found only with IF obesity is unclear, but it may be partly explained by the data in Figure 4 . This figure indicates that, although the reduction in ASF area is strongly associated with reduction in total fat and corresponds to a negative energy balance, the reduction in IF area is also associated with other factors, one of which may be an increase in physical activity through exercise training. Shimomura et al 27 found that plasma lipid intake and triglyceride synthesis in rats were reduced to a lesser extent in IF tissue than in ASF tissue in response to endurance training, resulting in a more prominent reduction of IF compared to ASF. Riechman et al 35 also reported that an association between daily physical activity and IF reduction was more prominent than the association between daily physical activity and ASF reduction. As we mentioned, however, detailed mechanisms that the specific exercise effect was modified by obesity phenotype is still unclear. To demonstrate the specific efficacy of exercise training, further, strictly controlled studies on associations between exercise training and IF reduction looking at obesity phenotype are needed.
There are some limitations of this study. First, there was a wide age range of subjects (21-66 y) including both pre-and postmenopausal women. Menopausal status and estrogen levels may independently influence total and abdominal fat accumulation. Second, activity of daily living with the exception of exercise training was not controlled. Hence, precise total energy balance could not be calculated. These factors might partly preclude our definitive conclusions. Third, to increase subject adherence to the weight loss programs during the intervention period, subjects were not randomized to the treatments. However, no difference was found in any variables between the DA and DE groups at baseline, which is independent of obesity phenotype (see Table 2 ). This suggests there was little, if any, influence on the measurement variables by assigning rather than randomizing subjects.
In conclusion, aerobic exercise training in conjunction to a controlled diet can have positive effects on reducing both total and abdominal fat under a strictly supervised weight loss program, and for both obesity phenotype, reductions in IF area and ASF area were positively associated with baseline values. That is, obesity phenotype modifies abdominal fat reduction in response to weight loss. Moreover, our data raises the possibility that for individuals with IF obesity, adding aerobic exercise training to a dietary weight-reduction program further (1.3 times) reduces IF compared with DA even if weight reductions would be identical in both two treatments (DA vs DE).
